Enliven Therapeutics (ELVN) had the highest return between August 16, 2022 and September 30, 2022 by a small-cap US stock, returning 91.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Enliven Therapeutics (ELVN) | 8/16/2022 - 9/30/2022 | 91.6% |
Prothena (PRTA) | 8/16/2022 - 9/30/2022 | 85.64% |
NRx Pharmaceuticals (NRXPW) | 8/16/2022 - 9/30/2022 | 44% |
Harrow Health (HROW) | 8/16/2022 - 9/30/2022 | 42% |
InnovAge (INNV) | 8/16/2022 - 9/30/2022 | 36.11% |
EVI Industries (EVI) | 8/16/2022 - 9/30/2022 | 34.27% |
Terns Pharmaceuticals (TERN) | 8/16/2022 - 9/30/2022 | 33.86% |
Larimar Therapeutics (LRMR) | 8/16/2022 - 9/30/2022 | 28.51% |
TSS, Inc Common Stock (TSSI) | 8/16/2022 - 9/30/2022 | 28.09% |
Cross Country Healthcare (CCRN) | 8/16/2022 - 9/30/2022 | 27.85% |
Pulse Biosciences (PLSE) | 8/16/2022 - 9/30/2022 | 27.07% |
Eve (EVEX) | 8/16/2022 - 9/30/2022 | 26.75% |
Astria Therapeutics (ATXS) | 8/16/2022 - 9/30/2022 | 26.26% |
NioCorp Developments Ltd Common Stock (NB) | 8/16/2022 - 9/30/2022 | 25% |
Cricut (CRCT) | 8/16/2022 - 9/30/2022 | 23.3% |
Bright Minds Biosciences (DRUG) | 8/16/2022 - 9/30/2022 | 23% |
Vertical Aerospace (EVTL) | 8/16/2022 - 9/30/2022 | 22.03% |
Studio City International (MSC) | 8/16/2022 - 9/30/2022 | 21.33% |
Ardelyx (ARDX) | 8/16/2022 - 9/30/2022 | 20.2% |
Sigma Lithium Resources (SGML) | 8/16/2022 - 9/30/2022 | 20.04% |
89bio (ETNB) | 8/16/2022 - 9/30/2022 | 19.88% |
Orange County Bancorp (OBT) | 8/16/2022 - 9/30/2022 | 19.69% |
LSI Industries (LYTS) | 8/16/2022 - 9/30/2022 | 17.76% |
Vigil Neuroscience (VIGL) | 8/16/2022 - 9/30/2022 | 16.67% |
ProKidney (PROK) | 8/16/2022 - 9/30/2022 | 16.26% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
